Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Just two years after the mega-merger that brought Warner Bros. and Discovery together, it’s discussing dramatic plans to break up.
Anglo American is cutting back diamond production to try to hedge against China’s continued ambivalence toward the gemstones.
Ford will spend $3 billion to expand production of its popular combustion engine large trucks; Volvo reported a record core operating profit.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Italy’s antitrust agency has opened an investigation into Dior and Armani over allegations of worker exploitation.
PricewaterhouseCoopers’ annual Global Entertainment & Media Outlook says the media industry has plenty of reasons for optimism.
The board of directors for Macy’s unanimously voted to end negotiations with Arkhouse and Brigade to take the company private.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Not only is sportswear and sneaker giant Nike faced with struggling financials, but it is also searching for its soul.
Commissioner Roger Goodell said the NFL is en route to allowing PE groups to take ownership stakes in franchises
Filings like these indicate that this pivot will likely have a domino effect on all other parts of the automotive industry.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.